SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,683 shares of the exchange traded fund’s stock after selling 375 shares during the quarter. Trust Co. of Vermont’s holdings in SPDR S&P Biotech ETF were worth $242,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $141,284,000. Affinity Asset Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after buying an additional 737,550 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the period. Finally, Sivik Global Healthcare LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $29,640,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $87.97 on Monday. The firm has a 50 day simple moving average of $94.09 and a 200 day simple moving average of $96.98. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company has a market cap of $6.71 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.